NeuroOne Medical Technologies Profit Margin

The latest profit margin for NMTC is -71.51% as of June 2026. That compares with -80.51% in the prior-year period — up 11.2% year over year. That is below the sector sector average of 13.09%. Investors often review this figure alongside NeuroOne Medical Technologies's historical trend and sector peers before judging valuation or financial health.

Over the past year, NMTC's profit margin moved from -80.51% to -71.51% — a 11.2% year-over-year increase. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in NeuroOne Medical Technologies's valuation or profitability profile.

Against its sector companies, NMTC currently prints -71.51% for profit margin, while the sector average sits near 13.09%. That is roughly 646.3% below the sector mean. Large gaps often invite a closer look at NeuroOne Medical Technologies's growth, margins, and balance sheet.

Profit Margin shows how effectively NeuroOne Medical Technologies converts resources into returns. At -71.51%, NMTC may look efficient or underperforming depending on peer benchmarks and trend direction. That compares with -80.51% in the prior-year period — up 11.2% year over year. Pair the percentage with revenue growth and leverage for a fuller health check.

After noting NMTC's profit margin (-71.51%), review year-over-year change from -80.51%, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.